Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study-Reference-Cited by-同舟云学术

Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study

Published:2023-07-01 Issue:7 Volume:25 Page:507-512
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Piona Claudia¹^ORCID,Marigliano Marco¹,Roncarà Chiara¹,Mozzillo Enza²^ORCID,Di Candia Francesca²,Zanfardino Angela³^ORCID,Iafusco Dario³,Maltoni Giulio⁴,Zucchini Stefano⁴,Piccinno Elvira⁵,Delvecchio Maurizio⁵^ORCID,Passanisi Stefano⁶,Lombardo Fortunato⁶,Bonfanti Riccardo⁷,Maffeis Claudio¹^ORCID

Affiliation:

1. Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, Department of Surgery, Dentistry, Pediatrics, and Gynecology, University of Verona, Verona, Italy.

2. Regional Center of Pediatric Diabetes, Department of Traslational and Medical Sciences, Section of Pediatrics, Federico II University, Naples, Italy.

3. Regional Center of Pediatric Diabetology “G.Stoppoloni”—University of Campania “Luigi Vanvitelli,” Naples, Italy.

4. Paediatric Endocrine Unit, University Hospital of Bologna Sant'Orsola-Malpighi, Bologna, Italy.

5. Metabolic Disorder and Diabetes Unit, “Giovanni XXIII” Children Hospital, Bari, Italy.

6. Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi,” University of Messina, Messina, Italy.

7. Pediatric Diabetes, San Raffaele Scientific Hospital and Vita Salute San Raffaele University, Milan, Milan.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0040

Reference15 articles.

1. Continuous Glucose Monitoring–Derived Data Report—Simply a Better Management Tool

2. International Consensus on Use of Continuous Glucose Monitoring

3. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

4. Positioning time in range in diabetes management

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between glycemia risk index and arterial stiffness in type 2 diabetes;Journal of Diabetes Investigation;2024-01-22

2. Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy;Diabetes Technology & Therapeutics;2024-01-01

3. Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review;Diabetes Therapy;2023-12-01

4. Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a new CGM Metric in Children and Adolescents with Type 1 Diabetes using Different Treatment Modalities;Diabetes Technology & Therapeutics;2023-10-30